A Rapid Advice Guideline of Traditional Chinese Medicine for Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19)

title: A Rapid Advice Guideline of Traditional Chinese Medicine for Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19)
Edition: Updated
Classification: Rapid advice guideline
Field: Comprehensive guideline
Countries and regions: China
Guide users: The worldwide medical workers who are taking care of people with COVID-19 from such as fever clinics, emergency departments, critical care departments, respiratory departments, traditional Chinese medicine departments, and integrative tradtional Chinese a
Evidence classification method: 采用GRADE系统对证据体质量进行评价和分级。基于RCT的系统评价起始质量为高,考虑五个降级因素:偏倚风险、间接性、异质性、不精确性、发表偏倚;而基于观察性研究的起始质量为低,考虑大效应量、剂量-效应关系和负偏倚三个升级因素,最后分为高、中、低、极低四个证据等级,以证据总结表形式呈现。
Development unit: China Center for Evidence-Based Traditional Chinese Medicine Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Registration time: 2020-07-13
Registration number: IPGRP-2020CN033
Purpose of the guideline: To develop a patient-oriented evidence-based rapid advice guideline assisting the clinical practice of traditional Chinese medicine (TCM) for COVID-19, as well as enhancing the ability to cope with the disease, and improving the application and influence